Literature DB >> 15556160

Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat.

Shona L Kirk1, Joanna C Neill, Declan N C Jones, Gavin P Reynolds.   

Abstract

Many atypical antipsychotic drugs, such as olanzapine, induce significant weight gain. However, ziprasidone produces minimal weight gain, the mechanism of which remains unclear. The aim of the present study was to investigate whether ziprasidone would reduce the acute effect of olanzapine on feeding behaviour. The results suggest that ziprasidone suppresses the significant increases in food intake produced by olanzapine, indicating that it has an intrinsic protective mechanism against drug-induced increases in food intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556160     DOI: 10.1016/j.ejphar.2004.10.015

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

Authors:  R Coccurello; A Caprioli; O Ghirardi; R Conti; B Ciani; S Daniele; A Bartolomucci; A Moles
Journal:  Psychopharmacology (Berl)       Date:  2006-05-13       Impact factor: 4.530

Review 2.  Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria.

Authors:  Robin Murray; Christoph U Correll; Gavin P Reynolds; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-01

Review 3.  Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.

Authors:  Tracy Swainston Harrison; Lesley J Scott
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  Atypical antipsychotic-induced weight gain: insights into mechanisms of action.

Authors:  James L Roerig; Kristine J Steffen; James E Mitchell
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

5.  Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats.

Authors:  M J Fell; J C Neill; C Rao; K M Marshall
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

6.  Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials.

Authors:  Hui Wu; Spyridon Siafis; Tasnim Hamza; Johannes Schneider-Thoma; John M Davis; Georgia Salanti; Stefan Leucht
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

7.  Receptor mechanisms of antipsychotic drug action in bipolar disorder - focus on asenapine.

Authors:  Gavin P Reynolds
Journal:  Ther Adv Psychopharmacol       Date:  2011-12

8.  Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors.

Authors:  Shona L Kirk; John Glazebrook; Ben Grayson; Joanna C Neill; Gavin P Reynolds
Journal:  Psychopharmacology (Berl)       Date:  2009-08-18       Impact factor: 4.530

Review 9.  Atypical antipsychotics and effects on feeding: from mice to men.

Authors:  Louise Benarroch; Chantel Kowalchuk; Virginia Wilson; Celine Teo; Melanie Guenette; Araba Chintoh; Yasika Nesarajah; Valerie Taylor; Peter Selby; Paul Fletcher; Gary J Remington; Margaret K Hahn
Journal:  Psychopharmacology (Berl)       Date:  2016-06-01       Impact factor: 4.530

10.  The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.

Authors:  M J Fell; N Anjum; K Dickinson; K M Marshall; L M Peltola; S Vickers; S Cheetham; J C Neill
Journal:  Psychopharmacology (Berl)       Date:  2007-06-21       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.